The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

Alnylam Pharmaceuticals , Inc. (NASDAQ:ALNY), a leader in RNA interference (RNAi) therapeutics, stands at a pivotal juncture as it seeks to capitalize on the burgeoning market for ...

The Company also provided an update on key corporate, clinical, and regulatory development initiatives ... of the updated KDIGO guidelines and potential approval of the recently accepted sNDA to ...

Introduction An organ transplant is a surgical procedure replacing a damaged organ with a healthy one. Diagnostics for organ transplants are cl ...

# The Supreme Court yesterday approved the Securities Commission’s bid to relegate its $221.55m claim against FTX behind those of the insolvent crypto exchange’s clients and other victims.

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

The Supreme Court yesterday approved the Securities ... Commission regarding the potential subordination of the Securities Commission’s asserted regulatory claim to claims by other customers ...

Investing.com -- Shares of Ionis Pharmaceuticals (NASDAQ: IONS) climbed 7% today after the company announced that regulatory agencies in the United States and Europe have accepted applications for a ...

We expect a mid-year submission of the sNDA for our Autoinjector product ... our dependence on the commercial success of FUROSCIX and, if approved, our other product candidates; risks related to the ...

The SEC has implemented new rules requiring commissioner approval for formal investigations, replacing the previous system ...